BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26466303)

  • 1. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    Leyh RG; Kofidis T; Strüber M; Fischer S; Knobloch K; Wachsmann B; Hagl C; Simon AR; Haverich A
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1426-31. PubMed ID: 12830064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue to treat vasoplegia due to a severe protamine reaction: a case report.
    Lutjen DL; Arndt KL
    AANA J; 2012 Jun; 80(3):170-3. PubMed ID: 22848976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
    Farina Junior JA; Celotto AC; da Silva MF; Evora PR
    Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methylene blue therapy for vasoplegia after cardiac surgery].
    Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
    Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
    Arevalo VN; Bullerwell ML
    AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene blue for burn-induced vasoplegia: case report and review of literature.
    Church JT; Posluszny JA; Hemmila M; To KB; Cherry-Bukowiec JR; Waljee J
    J Burn Care Res; 2015; 36(2):e107-11. PubMed ID: 25687361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery.
    Dagenais F; Mathieu P
    Can J Cardiol; 2003 Feb; 19(2):167-9. PubMed ID: 12601442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene Blue Is a Guanylate Cyclase Inhibitor That Does Not Interfere with Nitric Oxide Synthesis.
    Evora PR
    Tex Heart Inst J; 2016 Feb; 43(1):103. PubMed ID: 27047301
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylene blue treatment for vasoplegia and resultant isoelectric processed EEG (bispectral index).
    Thiele RH; Balireddy RK; Groves DS
    J Clin Anesth; 2012 Sep; 24(6):511-3. PubMed ID: 22986326
    [No Abstract]   [Full Text] [Related]  

  • 18. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.